The Objective Identification and Quantification of Interstitial Lung Abnormalities in Smokers
Samuel Y. Ash(Pulmonary and Critical Care Associates), George R. Washko(Brigham and Women's Hospital), Gary M. Hunninghake(Hubei University of Science and Technology), David A. Lynch(McMaster University), Alejandro A. Díaz(Brigham and Women's Hospital), Augustine M.K. Choi(Cornell University), Iván O. Rosas(Brigham and Women's Hospital), Rachel K. Putman(Brigham and Women's Hospital), James C. Ross(American College of Chest Physicians), Hiroto Hatabu(Harvard University), Jorge Onieva Onieva(Brigham and Women's Hospital), Rola Harmouche(Harvard University), Fernando J. Martínez(University of Massachusetts Chan Medical School), Raúl San Jośe Estépar(Brigham and Women's Hospital)
Cited by 72
Related Papers
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper
|European Respiratory Journal|2004|4.4k
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
|American Journal of Respiratory and Critical Care Medicine|2013|4.3k
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2018|4.1k
Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome
|Nature Immunology|2010|3k
Autophagy in Human Health and Disease
|New England Journal of Medicine|2013|2.6k